Person

Meghan Scanlon

Formerly SVP, Pres, Urology Pelvic Health, Boston Scientific

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$1.3M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 27, 2021BSXSale13,850$45.01$623K
Jun 24, 2021BSXSale16,450$44.03$724K

SEC reporting-owner ID (CIK) 1801586 · all filings on EDGAR